A detailed history of Efg Capital International Corp. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Efg Capital International Corp. holds 1,092 shares of CRL stock, worth $202,860. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,092
Holding current value
$202,860
% of portfolio
0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 02, 2023

BUY
$183.71 - $210.25 $200,611 - $229,593
1,092 New
1,092 $230 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.45B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Efg Capital International Corp. Portfolio

Follow Efg Capital International Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Capital International Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Capital International Corp. with notifications on news.